Le traitement par apomorphine en perfusion continue sous-cutanée dans la maladie de Parkinson : analyse rétrospective d’une série de 81 patients
- 1 March 2014
- journal article
- abstracts
- Published by Elsevier in Revue Neurologique
- Vol. 170 (3) , 205-215
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinationsParkinsonism & Related Disorders, 2010
- Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's diseaseParkinsonism & Related Disorders, 2009
- Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter studyMovement Disorders, 2008
- L’apomorphine en perfusion sous-cutanée continue dans le traitement de la maladie de ParkinsonRevue Neurologique, 2006
- Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson’s diseaseNeurological Sciences, 2003
- Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patientsMovement Disorders, 2002
- Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term resultsNeurological Sciences, 2001
- Apomorphine: An underutilized therapy for Parkinson's diseaseMovement Disorders, 2000
- Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow upJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five yearsMovement Disorders, 1993